|
Polymorphisms/mutations in candidate genes for asthma and related phenotypes |
||||||||
| Chromosomal |
Single nucleotide |
Phenotype |
Functional |
|||||
| location |
Number* |
Molecule |
polymorphism/mutation† |
related |
Population |
(in vitro) |
Reference |
|
|
|
||||||||
| 1p32 |
1 |
Histamine-N- |
C314T (Thr105Ile) |
Asthma |
Caucasian |
Yes |
[28] |
|
| methyl-transferase |
||||||||
| 2q33-34 |
2 |
CD28 |
T19int3C |
None |
Caucasian |
[S33] |
||
| CTLA-4 |
A49G |
None |
Caucasian |
[S33] |
||||
| C-318T |
None |
Caucasian |
||||||
| 3p21 |
3 |
CCR5 |
CC5-Δ32 |
Asthma |
Caucasian |
Yes |
[40] |
|
| No Association |
British/Australian |
[41] |
||||||
| 5q31-34 |
4 |
IL-4 |
C-590T |
Total IgE |
Japanese |
Yes |
[S34] |
|
| (= C-589T) |
Total IgE |
American |
[S35] |
|||||
| Specific IgE, wheeze |
Australian |
[S36] |
||||||
| FEV1 |
Caucasian |
[S37] |
||||||
| Atopic dermatitis |
Japanese |
[S38] |
||||||
| None |
Caucasian |
[S39] |
||||||
| C+33T |
Total IgE |
Japanese |
[S40] |
|||||
| 5 |
IL-5 |
None |
Australian |
[S41] |
||||
| 6 |
IL-13 |
C-1055T |
Allergic asthma |
Dutch |
[S42] |
|||
| identical |
||||||||
| C-1112T |
Total IgE |
American/German |
[19] |
|||||
| A-1512C |
||||||||
| C1923T |
||||||||
| G2525A |
||||||||
| C2580A |
||||||||
| C2749T |
||||||||
| Arg130Gln |
||||||||
| identical |
G4257A |
High IgE, atopic dermatitis |
German |
[S43] |
||||
| Gln110Arg |
Atopic and intrinsic |
British/Japanese |
[S44] |
|||||
| asthma |
||||||||
| 7 |
β2-AR |
G-1023A |
||||||
| C-709A |
||||||||
| G-654A |
||||||||
| C-468G |
||||||||
| C-406T |
||||||||
| T-367C |
Drug response |
Caucasian/African American |
Yes |
[24] |
||||
| T-47C |
(Haplotype studies) |
Asian/Hispanic-Latino |
||||||
| T-20C |
||||||||
| G46A (= Gly16Arg) |
||||||||
| C79G (= Gln27Glu) |
||||||||
| G252A |
||||||||
| C491T (= Thr164Ile) |
||||||||
| C523A |
||||||||
| Gly16Arg |
Drug response |
American |
Yes |
[27] |
||||
| FEV1 and FVC |
Hutterites |
[S45] |
||||||
| Asthma severity |
Not specified |
[S46] |
||||||
| Gly16Arg |
Nocturnal asthma |
American |
[25] |
|||||
| Steroid-dependent asthma |
American |
[S47] |
||||||
| None |
German |
[S48] |
||||||
| Drug response |
Not specified |
[S49] |
||||||
| Gln27Glu |
Drug response |
American |
Yes |
[27] |
||||
| Drug response |
Not specified |
[S49] |
||||||
| None |
German |
[S48] |
||||||
| Total IgE |
Caucasian |
[S50] |
||||||
| FEV1 |
British |
[S51] |
||||||
| 8 |
IRF-1 |
-300 G/T |
None |
Japanese |
[S52] |
|||
| 4396 A/G |
None |
|||||||
| 6355 G/A |
None |
|||||||
| 9 |
CD14 |
-159 C → T |
Total IgE |
Caucasian |
[S53] |
|||
| None |
Hispanic |
[S53] |
||||||
| Total IgE |
British |
[S54] |
||||||
| None |
Japanese |
[S54] |
||||||
| 5q35 |
10 |
LTC4 synthase |
-444 C |
Aspirin-induced asthma |
Caucasian |
Yes |
[30] |
|
| None |
American |
No |
[S55] |
|||||
| 6p21 |
11 |
HLA-II |
Specific IgE |
Multiple |
[S56] |
|||
| TNF |
-308 TNF2 |
BHR |
Caucasian |
[S57] |
||||
| LT-α |
LT alpha NcoI*1/ |
Asthma |
British |
[S58] |
||||
| TNF-308*2 haplotype |
||||||||
| -308 TNF1 |
Asthma |
Australian |
[S59] |
|||||
| LT-alpha*2 |
Asthma |
|||||||
| 6p21-12 |
24 |
PAF-acetyl-hydrolase |
Ile198Thr |
Atopic Asthma/ |
German/British |
Yes |
[S60] |
|
| total IgE |
||||||||
| Ala379Val |
Asthma/specific IgE |
Yes |
||||||
| Arg92His |
None |
Yes |
||||||
| 10 |
12 |
5-LO (promoter) |
(GGGCGG)n = 3–6 |
Drug Response |
Not specified |
Yes |
[29] |
|
| 11q12-13 |
14 |
CC16 |
A38G |
Asthma |
Australian |
[S61] |
||
| None |
British/Japanese |
[S62] |
||||||
| 15 |
FcεR1-β |
lle181Leu |
Atopy |
British |
No |
[S63] |
||
| Japanese |
[S64] |
|||||||
| Leu181/Leu183 |
Atopy, BHR |
British/Australian |
No |
[S65] |
||||
| None |
Australian |
[S51] |
||||||
| E237G (= Gly237Glu) |
Atopy |
Australian |
No |
[S66] |
||||
| None |
Japanese |
[S67] |
||||||
| RsaI_in2*B |
Asthma |
Australian |
[S68] |
|||||
| RsaI_ex7 (+ RsaI_in2*B) |
Total IgE, atopic |
Not specified |
[S69] |
|||||
| dermatitis, asthma |
||||||||
| -109C/T |
Total IgE |
Japanese |
[S70] |
|||||
| 13 |
GSTP1 |
Ile105Val |
IgE/Skin Test/FEV1 |
Caucasian |
[S71] |
|||
| 12q13 |
17 |
STAT6 |
G2964A |
Asthma |
Japanese |
[S72] |
||
| 12q14 |
16 |
IFN-γ |
None |
Australian/Venezuelan |
[S73] |
|||
| 12q24 |
18 |
NO-synthase 1 |
(AAT)n ≥ 12 |
Exhaled NO |
Mixed |
[S74] |
||
| 14p11 |
19 |
TCR |
VA8.1(*)2 |
Specific IgE |
Caucasian |
[S75] |
||
| 20 |
Mast cell chymase |
MCC BstXI |
Eczema |
Japanese |
[S76] |
|||
| Total IgE |
Not specified |
[S77] |
||||||
| None |
Japanese |
[S78] |
||||||
| None |
Italian |
[S79] |
||||||
| Atopic dermatitis |
Japanese |
[S80] |
||||||
| With high IgE |
||||||||
| 16p12-p11 |
21 |
IL-4Rα |
Q576R (= Arg551Gln) |
Atopy, high IgE |
American |
Yes |
[S81] |
|
| Asthma severity (FEV1) |
American |
[S82] |
||||||
| None |
Italian |
[S83] |
||||||
| Atopic dermatitis |
Japanese |
[S84] |
||||||
| Low IgE |
German |
Yes |
[20] |
|||||
| S503P (= 478Pro) |
Low IgE |
[20] |
||||||
| E400A |
None |
|||||||
| C431R |
None |
|||||||
| Ile50Val |
IgE/atopic asthma |
Japanese |
Yes |
[S85] |
||||
| None |
Japanese |
[S86] |
||||||
| Ile50Val |
||||||||
| Ser727Ala |
||||||||
| Glu375Ala |
||||||||
| Cys406Arg |
Atopy/asthma |
Hutterites/Caucasian |
[21] |
|||||
| Ser411Leu |
(Haplotype studies) |
African American/Hispanic |
||||||
| Ser761Pro |
||||||||
| Ser478Pro |
||||||||
| Gln551Arg |
||||||||
| 17q11-q12 |
22 |
RANTES |
G-401A |
Atopic dermatitis |
Caucasian |
Yes |
[43] |
|
| identical |
||||||||
| G-403A |
Asthma, atopy |
Caucasian |
[44] |
|||||
| Xq |
23 |
IL-13Rα1 |
A1398G |
Total IgE |
British |
[S44] |
||
|
Divergent positions of identical mutations are due to different database accession numbers used for reference. * Numbers refer to molecules in Supplementary Figure 1. † Nomenclature as in references. β2-AR, β2 adrenergic receptor; BHR, bronchial hyperresponsiveness; CC16, Clara cell protein 16; CCR5, CC chemokine receptor 5; CD, cluster of differentiation; FcεR1-β, Fc epsilon receptor 1 beta (IgE receptor); FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; GSTP1, glutathione-S-transferase 1; HLA, human leukocyte antigen; IFN, interferon; IL, interleukin; IL-4/13 R, interleukin 4/13 receptor; IRF-1, interferon regulatory factor 1; 5-LO, 5-lipoxygenase; LT, leukotriene; LT-α, lymphotoxin α; LTC4, leukotriene C4 synthase; NO, nitric oxide; PAF, platelet activating factor; RANTES, regulated on activation, normal T cell expressed and secreted; STAT6, signal transducer and activator of transcription 6; TCR, T-cell receptor; TNF, tumor necrosis factor. | ||||||||
Sengler et al. Respiratory Research 2002 3:7 doi:10.1186/rr179 |
||||||||